University of Colorado Cancer Center - Anschutz Cancer Pavilion
Aurora, Colorado, United States
Cancer treatment center in Aurora, Colorado
1665 Aurora Court Anschutz Cancer Pavilion, Aurora, CO 80045
About University of Colorado Cancer Center - Anschutz Cancer Pavilion
"Because we are in a health care setting, masks are still required in all facilities. Thank you for helping keep our patients and staff safe."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
22
Pfizer
22
Gynecologic Oncology Group
10
Hoffmann-La Roche
10
SWOG Cancer Research Network
8
Radiation Therapy Oncology Group
5
Genentech, Inc.
4
Alliance for Clinical Trials in Oncology
3
Incyte Corporation
3
Novartis Pharmaceuticals
3
OncoMed Pharmaceuticals, Inc.
3
Clinical Trials at University of Colorado Cancer Center - Anschutz Cancer Pavilion
During the past decade, University of Colorado Cancer Center - Anschutz Cancer Pavilion conducted 62 clinical trials. In the 10-year time frame, 62 clinical trials started and 65 clinical trials were completed, i.e. on
average, 104.8% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 25 clinical trials were completed. i.e. 113.6%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Aldesleukin With or Without Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Melanoma
1999-12-01
2011-05-01
Completed
185
Bevacizumab and Docetaxel in Treating Women With Locally Advanced or Metastatic Breast Cancer
2002-07-01
Completed
27
SR34006 Compared to Vitamin K Antagonist (VKA) in the Treatment of Pulmonary Embolism
2003-06-01
2005-10-01
Completed
The PRECISE Trial: Study of IL13-PE38QQR Compared to GLIADEL Wafer in Patients With Recurrent Glioblastoma Multiforme
2004-02-01
2007-03-01
Completed
300
MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic Melanoma
2004-09-01
2009-10-01
Completed
1,783
Patupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal Cancer
2005-11-01
Completed
829
A Study of Talimogene Laherparepvec in Stage IIIc and Stage IV Malignant Melanoma
2005-12-01
2009-05-01
Completed
50
ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer
2006-11-01
Completed
37
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "University of Colorado Cancer Center - Anschutz Cancer Pavilion" #1 sponsor was "National Cancer Institute (NCI)" with 22 trials, followed by "Pfizer" with 22 trials
sponsored, "Gynecologic Oncology Group" with 10 trials sponsored, "Hoffmann-La Roche" with 10 trials sponsored and "SWOG Cancer Research Network"
with 10 trials sponsored. Other sponsors include 70 different institutions and
companies that sponsored additional 59 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "University of Colorado Cancer Center - Anschutz Cancer Pavilion"
#1 collaborator was "National Cancer Institute (NCI)" with 31 trials as a collaborator, "NRG Oncology" with 14 trials as a collaborator, "Astellas Pharma Inc" with 4 trials as a collaborator, "Merck Sharp & Dohme LLC" with 3 trials as a collaborator and "AstraZeneca" with 2 trials as a collaborator. Other collaborators include 24 different institutions and companies that were
collaborators in the rest 31 trials.
Clinical Trials Conditions at University of Colorado Cancer Center - Anschutz Cancer Pavilion
According to Clinical.Site data, the most researched conditions in "University of Colorado Cancer Center - Anschutz Cancer Pavilion" are
"Melanoma" (6 trials), "Prostate Cancer" (6 trials), "Breast Cancer" (5 trials), "Ovarian Clear Cell Cystadenocarcinoma" (5 trials) and "Recurrent Uterine Corpus Carcinoma" (5 trials). Many other conditions were trialed in "University of Colorado Cancer Center - Anschutz Cancer Pavilion" in a lesser frequency.
Clinical Trials Intervention Types at University of Colorado Cancer Center - Anschutz Cancer Pavilion
Most popular intervention types in "University of Colorado Cancer Center - Anschutz Cancer Pavilion" are "Drug" (122 trials), "Other" (38 trials), "Biological" (28 trials), "Procedure" (11 trials) and "Radiation" (7 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (21 trials), "Placebo" (9 trials), "Bevacizumab" (7 trials), "Atezolizumab" (6 trials) and "Carboplatin" (6 trials). Other intervention names were less common.
Clinical Trials Genders at University of Colorado Cancer Center - Anschutz Cancer Pavilion
The vast majority of trials in "University of Colorado Cancer Center - Anschutz Cancer Pavilion" are
106 trials for "All" genders, 29 trials for "Female" genders and 12 trials for "Male" genders.
Clinical Trials Status at University of Colorado Cancer Center - Anschutz Cancer Pavilion
Currently, there are NaN active trials in "University of Colorado Cancer Center - Anschutz Cancer Pavilion".
undefined are not yet recruiting,
21 are recruiting,
27 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 78 completed trials in University of Colorado Cancer Center - Anschutz Cancer Pavilion,
1 suspended trials,
and 17 terminated clinical trials to date.
Out of the total trials that were conducted in University of Colorado Cancer Center - Anschutz Cancer Pavilion, 48 "Phase 1"
clinical trials were conducted, 67 "Phase 2" clinical
trials and 37 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 4 trials that are defined as “Not Applicable".